Objective: To assess the safety of recombinant human Apo-2 ligand(rh-Apo2L) in patients with advanced cancer.

• 目的:观察晚期恶性肿瘤患者对重组人凋亡素2配体(rh-Apo2L,又称肿瘤坏死因子相关凋亡诱导配体)静脉滴注后的安全性。